Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ltc Properties | LTC | Feb 28, 2025 | 34.89 | +0.35 |
Lucas GC | LGCL | Feb 28, 2025 | 0.53 | -4.12 |
Lucid Diagnostics | LUCD | Feb 28, 2025 | 1.48 | -1.33 |
Lucid Group | LCID | Feb 28, 2025 | 2.22 | -0.45 |
Lucky Strike Entertainment A | LUCK | Feb 28, 2025 | 10.68 | 0.00 |
Lufax ADR | LU | Feb 28, 2025 | 2.90 | -7.64 |
Lululemon Athletica | LULU | Feb 28, 2025 | 365.61 | +0.95 |
Lulus Fashion Lounge | LVLU | Feb 28, 2025 | 0.68 | -5.55 |
Lumen Technologies | LUMN | Feb 28, 2025 | 4.72 | +4.66 |
Lument Finance Trust | LFT | Feb 28, 2025 | 2.79 | +1.09 |
Lument Finance Trust A Pref | LFT-A | Feb 28, 2025 | 22.30 | 0.00 |
Lumentum | LITE | Feb 28, 2025 | 70.33 | +1.02 |
Luminar Technologies A | LAZR | Feb 28, 2025 | 5.20 | +1.17 |
Luokung Technology | LKCO | Feb 28, 2025 | 1.66 | -0.36 |
Luxfer | LXFR | Feb 28, 2025 | 12.20 | +2.95 |
Lxp Industrial Trust | LXP | Feb 28, 2025 | 8.96 | +1.70 |
LXP Industrial Trust C Pref | LXP-C | Feb 28, 2025 | 47.65 | -0.05 |
Lyell Immunopharma | LYEL | Feb 28, 2025 | 0.71 | -0.28 |
Lyft A | LYFT | Feb 28, 2025 | 13.34 | +2.46 |
LyondellBasell Industries Nv A | LYB | Feb 28, 2025 | 76.83 | +1.11 |
Lyra Therapeutics | LYRA | Feb 28, 2025 | 0.21 | +5.52 |
Lytus Technologies | LYT | Feb 28, 2025 | 0.17 | -3.67 |
M&T Bank | MTB | Feb 28, 2025 | 191.72 | +1.20 |
M&T Bank ADR Prej J | MTB-J | Feb 28, 2025 | 27.13 | -0.07 |
M&T Bank H Pref | MTB-H | Feb 28, 2025 | 25.35 | +1.14 |
M-tron Industries | MPTI | Feb 28, 2025 | 39.56 | -1.49 |
M/I Homes | MHO | Feb 28, 2025 | 117.13 | +0.18 |
M3-Brigade Acquisition V | MBAV | Feb 28, 2025 | 10.14 | 0.00 |
M3-Brigade Acquisition V | MBAVU | Feb 28, 2025 | 10.20 | 0.00 |
MAC Copper | MTAL | Feb 28, 2025 | 10.07 | -1.95 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.